<DOC>
	<DOCNO>NCT02761980</DOCNO>
	<brief_summary>This single dose study evaluate efficacy safety Fixed Dose Combination Ibuprofen 250 mg/ Acetaminophen 500 mg tablet healthy male patient fever . Results Fixed Dose Combination product compare individual component Ibuprofen 250 mg Acetaminophen 500 mg also compare placebo .</brief_summary>
	<brief_title>A Study Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Fever</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Antipyretics</mesh_term>
	<criteria>1 . Healthy male subject , time screening , 18 55 year age , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . 2 . The subject must normal , stable body temperature Screening Day 0 . If subject 's oral temperature 97.4°F 98.8°F , 2 additional oral temperature reading obtain within 30 minute period . These 3 consecutive temperature reading must 97.4°F 98.8°F , high value within 0.4°F low temperature value . 3 . Body Mass Index ( BMI ) 17.5 37.0 kg/m2 ; total body weight 50 kg ( 110 lb ) Screening . 4 . The subject demonstrably adequate vein , visual inspection , IV catheter insertion . 1 . Evidence history clinically significant laboratory abnormality , hematological , renal , endocrine , pulmonary , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( exclude untreated , asymptomatic , seasonal allergy time dose ) within last 5 year may increase risk associate study participation . 2 . Subjects gastrointestinal disorder ( eg , gastrectomy , tracheostomy , esophageal surgery , short gut syndrome , peptic ulcer disease , know suspected obstructive disease , previous gastrointestinal surgery , felinization esophagus , hypomotility gastrointestinal track ) could affect absorption , metabolism , excretion study medication affect result ingestible thermometer . 3 . Subjects risk excessive bleeding . 4 . Subjects history nasal polyp , angioedema , significant actively treat bronchospastic disease . 5 . Screening supine blood pressure ≤90 ≥140 mm Hg ( systolic ) ≤50 ≥90 mm Hg ( diastolic ) , follow least 5 minute supine rest . If blood pressure ( BP ) ≤90 ≥140 mm Hg ( systolic ) ≤50 ≥90 mm Hg ( diastolic ) , BP repeat two time average three consecutive BP value use determine subject 's eligibility . 6 . Screening supine 12 lead ECG demonstrate QTc &gt; 450 msec QRS interval &gt; 120 msec Screening Day 1 prior RSE administration . If QTc exceed 450 msec , QRS exceed 120 msec , ECG repeat two time average three consecutive QTc QRS value use determine subject 's eligibility . 7 . The subject history recurrent acute chronic infection type finding suggestive occult infection , tuberculosis , sinusitis , urinary tract infection , respiratory tract dental ( abscess ) infection , etc. , positive QuantiFERON Tuberculosis , Hepatitis B surface antigen , Hepatitis C antibody , and/or Human immunodeficiency virus ( HIV ) test Screening . Also exclude subject frequent ( 3 outbreak per year ) , recurrent oral genital herpes , recurrent herpes zoster , infection otherwise judge investigator potential exacerbation participation study . 8 . Subjects experience cold/flu symptom ( ie , runny nose , cough , and/or fever ) within 2 week prior first administration study treatment . 9 . Subjects reduction heart rate ≤50 beat per minute deem high risk syncope and/or hypotension per clinical judgment investigator follow carotid sinus massage procedure .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>ibuprofen ; acetaminophen ; induce fever ; fever</keyword>
</DOC>